Analysis of European mitochondrial haplogroups with Alzheimer disease risk

Neuroscience Letters

Volumn 365, Issue 1, 2004, Pages 28-32

  Van Der Walt, Joelle M ^a   Dementieva, Yulia A ^b   Martin, Eden R ^a   Scott, William K ^a   Nicodemus, Kristin K ^a   Kroner, Charles C ^a   Welsh Bohmer, Kathleen A ^a   Saunders, Ann M ^c   Roses, Allen D ^c   Small, Gary W ^d   Schmechel, Donald E ^a   Murali Doraiswamy, P ^a   Gilbert, John R ^a   Haines, Jonathan L ^e   Vance, Jeffery M ^a   Pericak Vance, Margaret A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MARSHALL UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; APOE; Mitochondrial haplogroups; mtDNA

Indexed keywords

APOENZYME; MITOCHONDRIAL DNA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; DNA, MITOCHONDRIAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MITOCHONDRIA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS;

EID: 3242707016     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.04.051     Document Type: Article

References (20)

1. Andersen K., Launer L.J., Dewey M.E., Letenneur L., Ott A., Copeland J.R.M., Dartigues J.F., Kragh-Sorensen P., Baldereschi M., Brayne C., Lobo A., Martinez-Lage J.M., Stijnen T., Hofman A. Gender differences in the incidence of AD and vascular dementia - The EURODEM Studies. Neurology. 53:1999;1992-1997
2. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38:1995;357-366
3. Carrieri G., Bonafe M., De Luca M., Rose G., Varcasia O., Bruni A., Maletta R., Nacmias B., Sorbi S., Corsonello F., Feraco E., Andreev K.F., Yashin A.I., Franceschi C., De Benedictis G. Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease. Hum. Genet. 108:2001;194-198
4. Chinnery P.F., Taylor G.A., Howell N., Andrews R.M., Morris C.M., Taylor R.W., McKeith I.G., Perry R.H., Edwardson J.A., Turnbull D.M. Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology. 55:2000;302-304
5. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923
6. Cottrell D.A., Borthwick G.M., Johnson M.A., Ince P.G., Turnbull D.M. The role of cytochrome c oxidase deficient hippocampal neurones in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 28:2002;390-396
7. De Benedictis G., Tan Q., Jeune B., Christensen K., Ukraintseva S.V., Bonafe M., Franceschi C., Vaupel J.W., Yashin A.I. Recent advances in human gene-longevity association studies. Mech. Ageing Dev. 122:2001;909-920
8. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., Van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 278:1997;1349-1356
9. Finnila S., Hassinen I.E., Ala-Kokko L., Majamaa K. Phylogenetic network of the mtDNA haplogroup U in Northern Finland based on sequence analysis of the complete coding region by conformation-sensitive gel electrophoresis. Am. J. Hum. Genet. 66:2000;1017-1026
10. Haynes C., Speer M.C., Peedin M., Roses A.D., Haines J.L., Vance J.M., Pericak-Vance M.A. PEDIGENE: a comprehensive data management system to facilitate efficient and rapid disease gene mapping. Am. J. Hum. Genet. 57(4):1995;A193
11. Kish S.J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L.J., Wilson J.M., DiStefano L.M., Nobrega J.N. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59:1992;776-779
12. Macaulay V., Richards M., Hickey E., Vega E., Cruciani F., Guida V., Scozzari R., Bonne-Tamir B., Sykes B., Torroni A. The emerging tree of West Eurasian mtDNAs: a synthesis of control- region sequences and RFLPs. Am. J. Hum. Genet. 64:1999;232-249
13. Majamaa K., Finnila S., Turkka J., Hassinen I.E. Mitochondrial DNA haplogroup U as a risk factor for occipital stroke in migraine. Lancet. 352:1998;455-456
14. McKhann G., Drachman D., Folstein M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944
15. Mortensen E.L., Hogh P. A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology. 57:2001;89-95
16. Oliveira S.A., Martin E.R., Scott W.K., Nicodemus K.K., Small G.W., Schmechel D.E., Doraiswamy P.M., Roses A.D., Saunders A.M., Gilbert J.R., Haines J.L., Vance J.M., Pericak-Vance M.A. The Q7R Saitohin gene polymorphism is not associated with Alzheimer disease. Neurosci. Lett. 347:2003;143-146
17. Small G.W., Rabins P.V., Barry P.P., Buckholtz N.S., DeKosky S.T., Ferris S.H., Finkel S.I., Gwyther L.P., Khachaturian Z.S., Lebowitz B.D., McRae T.D., Morris J.C., Oakley F., Schneider L.S., Streim J.E., Sunderland T., Teri L.A., Tune L.E. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA. 278:1997;1363-1371
18. Swerdlow R.H., Parks J.K., Cassarino D.S., Maguire D.J., Maguire R.S., Bennett J.P. Jr., Davis R.E., Parker W.D. Jr. Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology. 49:1997;918-925
19. van der Walt J.M., Nicodemus K.K., Martin E.R., Scott W.K., Nance M.A., Watts R.L., Hubble J.P., Haines J.L., Koller W.C., Lyons K., Pahwa R., Stern M.B., Colcher A., Hiner B.C., Jankovic J., Ondo W.G., Allen F.H. Jr., Goetz C.G., Small G.W., Mastaglia F., Stajich J.M., McLaurin A.C., Middleton L.T., Scott B.L., Schmechel D.E., Pericak-Vance M.A., Vance J.M. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am. J. Hum. Genet. 72:2003;804-811
20. Wallace D.C. Mitochondrial DNA sequence variation in human evolution and disease. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8739-8746